STOCK TITAN

Virtuix Sells First Omni One Systems to U.S. Department of Veterans Affairs, the Largest Integrated Healthcare System in U.S.

Virtuix’s first sale to the VA introduces Omni One into veteran healthcare and may support wider adoption through the VA’s immersive technology network.

(Positive)
Tags

Virtuix (VTIX) has sold its Omni One full-body simulation systems to the U.S. Department of Veterans Affairs for initial deployment at the Valor Center at the Detroit VA Medical Center.

The systems will be evaluated for potential use in therapeutic applications and holistic health programs within the VA, the largest integrated healthcare system in the U.S. Virtuix links this milestone to a potential pathway into the VA’s “VA Immersive” network, which has expanded to more than 145 VA facilities nationwide. The company also highlights recent Omni One deployments at Florida Gulf Coast University and Rutgers University for occupational therapy, neurological rehabilitation, and AI-assisted neurodivergent therapy, alongside growing use of its technology across multiple U.S. military branches.

Loading...
Loading translation...

Positive

  • First VA sale of Omni One systems, with initial deployment at Detroit VA Medical Center
  • Access to VA Immersive network that has expanded to more than 145 VA facilities
  • New healthcare use cases via deployments at Florida Gulf Coast University and Rutgers University
  • Growing U.S. defense footprint including AFWERX SBIR Phase I funding and multi-branch military programs

Negative

  • None.
Argus 15 min delay
-3.77% vs previous close $1.02 last price 3.3x rel. volume Open Argus
Details

Market reaction after Omni One VA sale: VTIX -3.77%

$0.98 $1.15 Day Range
$34.65M Market Cap

Following this news, VTIX has declined 3.77%, reflecting a moderate negative market reaction. Our momentum scanner has triggered 6 alerts so far, indicating moderate trading interest and price volatility. The stock is currently trading at $1.02. Trading volume is very high at 3.3x the average, suggesting heavy selling pressure.

Data tracked by StockTitan Argus (15 min delayed). Upgrade to Gold for real-time data.

Market Context

The Sep 8 Navy MWR announcement specified 2 units; today’s VA announcement likewise described an ini...
Analysis

The Sep 8 Navy MWR announcement specified 2 units; today’s VA announcement likewise described an initial Omni One government deployment, connecting the healthcare sale to Virtuix’s recent government-customer expansion without disclosing a unit count.

Key Figures

VA Immersive facilities: More than 145 facilities
VA Immersive facilities
More than 145 facilities
Nationwide VA Immersive program

Historical Context

1 past event · Latest: Sep 08
1 event
  1. Sep 08

    Government system sale

    24h Move
    -9.5%

    First Omni One Enterprise sale to Navy MWR included two units.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

post-traumatic stress disorder, occupational therapy, sbir program, cooperative research and development agreement
4 terms
post-traumatic stress disorder medical
"including post-traumatic stress disorder (PTSD), anxiety, pain management"
A mental health condition that can develop after a person experiences or witnesses a traumatic event, causing persistent symptoms such as intrusive memories, heightened stress reactions, avoidance of reminders, and trouble sleeping or concentrating. For investors it matters because it can reduce employee productivity, increase healthcare and disability costs, alter consumer behavior, and create demand for treatment and support services—think of a business whose systems keep freezing after a shock, requiring ongoing fixes and higher operating costs.
occupational therapy medical
"including post-traumatic stress disorder (PTSD), anxiety, pain management, and occupational therapy"
Occupational therapy is a healthcare service that helps people recover, adapt, or learn everyday skills needed for work, self-care and daily activities after illness, injury, or developmental challenges. For investors, it signals a market for durable services, training devices, home modifications and long-term care spending — think of it as a practical rehabilitation “coach” that creates steady demand for equipment, clinics and related technology.
sbir program financial
"Phase I funding through the AFWERX SBIR program"
The SBIR program is a U.S. government funding initiative that awards competitive grants and contracts to small businesses to develop and test innovative technologies with commercial potential. For investors, an SBIR award is a signal of technical validation and non-dilutive capital—think of it as a government-sponsored prototype grant that helps a small company de-risk early research and reach milestones without giving up ownership, increasing the chances of future market-ready products or contracts.
cooperative research and development agreement regulatory
"a cooperative research and development agreement with the U.S. Navy"
A cooperative research and development agreement (CRADA) is a formal partnership between a government research lab and a private company to jointly develop technology or products, with each side contributing staff, facilities, or funding while agreeing on how results and patents are shared. For investors, a CRADA can speed development, lower costs and give a company access to specialized government expertise or facilities—similar to renting a well-equipped workshop with shared ownership of whatever is built—potentially improving the odds of commercial success.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

Initial Deployment at Detroit VA Medical Center Expands Omni One into Veteran Healthcare for Therapeutic Applications

Sale Provides Potential Pathway to VA Immersive Network Spanning More Than 145 Facilities Nationwide

AUSTIN, Texas, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Virtuix Holdings Inc. (NASDAQ: VTIX), a leading developer of AI-driven, full-body simulation systems, today announced the sale of Omni One systems to the U.S. Department of Veterans Affairs (“VA”). The systems will be deployed at the Valor Center at the VA Medical Center in Detroit, Michigan, for evaluation and potential use across therapeutic applications and holistic health programs.

The initial deployment introduces Omni One into the nation’s largest integrated healthcare system and represents an important milestone in Virtuix’s expansion into healthcare and therapeutic applications. Through its established “VA Immersive” program, the VA is already deploying virtual reality and other immersive technologies across a range of clinical applications, including post-traumatic stress disorder (PTSD), anxiety, pain management, and occupational therapy.

Virtuix believes the initial VA deployment could represent a significant long-term opportunity for Omni One. VA Immersive has expanded to more than 145 VA facilities nationwide, with a stated goal of reaching all interested VA healthcare systems.

“Our first sale to the Department of Veterans Affairs, the largest healthcare system in the U.S., is an important milestone in Virtuix’s expansion into healthcare,” said Jan Goetgeluk, Founder, Chairman and CEO. “The VA has been a leader in adopting immersive technologies to improve care for Veterans, and we’re proud of the potential for our technology to help Veterans. Beyond the initial deployment in Detroit, we believe the VA healthcare system represents a meaningful long-term opportunity for our platform.”

The VA deployment follows recent Omni One installations at leading academic institutions exploring the platform for healthcare and therapeutic applications. Florida Gulf Coast University’s Marieb College of Health & Human Services is evaluating Omni One for occupational therapy and neurological rehabilitation. Rutgers University’s WINLAB has deployed Omni One for AI-assisted neurodivergent therapy, including autism therapy applications for children.

Virtuix’s expansion into the VA healthcare system comes alongside growing momentum in the U.S. defense sector, with programs and deployments spanning all four major branches of the U.S. military. Recent milestones include selection by the U.S. Air Force for Phase I funding through the AFWERX SBIR program to advance its Virtual Terrain Walk platform; sales to the U.S. Navy MWR program; appointment as lead systems integrator for a U.S. Marine Corps infantry fireteam trainer; integration of Omni One into a counter-drone training system being evaluated by the Marine Corps; sales to the U.S. Air Force Academy, U.S. Military Academy at West Point, Air National Guard, and Yokota Air Base in Japan; and a cooperative research and development agreement with the U.S. Navy. Together, these initiatives demonstrate the growing adoption of Virtuix’s AI-driven, full-body simulation technology across a broad range of military training, mission planning, and simulation applications.

About Virtuix

Virtuix Holdings Inc. (NASDAQ: VTIX) is a developer of AI-driven, full-body immersive simulation systems and the creator of the “Omni” omni-directional treadmill. Virtuix’s technology lets users physically move through virtual and AI-generated environments. The Company’s products are deployed across consumer entertainment, defense training and simulation, robotics, healthcare, research, and enterprise applications involving organizations including NASA, Tesla, KBR, and Sirica Therapeutics. The Company’s growing federal and defense footprint includes programs, deployments, and research initiatives involving the U.S. Army, Marine Corps, Navy, and Air Force.

Virtuix continues to expand the Omni brand from immersive entertainment into a broader, full-body simulation technology platform serving multiple commercial and government markets. For more information, visit virtuix.com or the Company’s new Investor Relations website at invest.virtuix.com.

Cautionary Note Regarding Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include, but are not limited to, statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as “may,” “will,” “intend,” “should,” “believe,” “expect,” “anticipate,” “project,” “estimate,” “could,” “would,” “potential” or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements in this press release include, without limitation, statements regarding the Company’s sales and expansion plans, plans to pursue strategic acquisitions, potential impacts on future revenues or shareholder value, and the Company’s position in the defense training market. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company’s expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the Company’s ability to identify, negotiate, and complete acquisitions on favorable terms or at all; the ability to successfully integrate any acquired business; risks related to government contracting, including contract cancellations, modifications, or funding changes; the uncertainties related to market conditions; and other factors discussed in the “Risk Factors” section of the Company’s registration statement filed with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company’s filings with the SEC, which are available for review at www.sec.gov. The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof.

Visit Us on Social Media:
LinkedIn
Instagram
Facebook
YouTube
TikTok
X

Company Contact
Lauren Premo
Virtuix Inc.
press@virtuix.com

Investor Relations Contact
Chris Tyson
MZ Group
Direct: 949-491-8235
VTIX@mzgroup.us


FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Where will the VA initially deploy Virtuix’s Omni One systems?

The initial deployment of Virtuix’s Omni One systems will take place at the Valor Center at the VA Medical Center in Detroit, Michigan, where they will be evaluated for potential use across therapeutic applications and holistic health programs.

What therapeutic areas is the VA Immersive program targeting with immersive technologies?

Through its VA Immersive program, the VA is already deploying virtual reality and other immersive technologies across clinical applications including post-traumatic stress disorder (PTSD), anxiety, pain management, and occupational therapy.

What recent U.S. defense sector initiatives involve Virtuix’s technology?

Recent initiatives include Phase I funding from the U.S. Air Force through the AFWERX SBIR program for the Virtual Terrain Walk platform, sales to the U.S. Navy MWR program, appointment as lead systems integrator for a U.S. Marine Corps infantry fireteam trainer, integration of Omni One into a counter-drone training system being evaluated by the Marine Corps, sales to the U.S. Air Force Academy, U.S. Military Academy at West Point, Air National Guard, and Yokota Air Base in Japan, and a cooperative research and development agreement with the U.S. Navy.

Keep reading